Addus HomeCare (ADUS) is positioning itself for growth in 2026, with executives highlighting a strategic push toward a $275 million acquisition of AccentCare’s personal care services division, expected to close by the first quarter of 2027. The deal, structured to align with Gentiva’s prior acquisition model—buying a personal care division from a larger home health and hospice provider with limited back-office infrastructure—aims to expand the company’s footprint across 10 states, with over 90% of operations concentrated in Texas, Illinois, California, and Arizona. AccentCare’s revenue run rate is $280 million, with an EBITDA margin just under 10%, compared to Addus’s Personal Care Services division’s gross margin in the upper 20% range. The acquisition is expected to improve margins over 12–18 months through synergies and operational integration, with pro forma leverage post-deal projected at just over 1.0x, though the company anticipates being debt-free at closing.
The company’s operational focus extends beyond acquisitions, with Q2 2026 data showing 9.8% growth in home nursing admissions and a 4%–5% revenue share from home nursing services. Revenue growth targets for 2026 sit at 3%–5%, with the upper end of that range expected to be realized. Same-store hours growth is projected at 2%–2.5% year-over-year. Consolidated fill rates sit at 84%–85%, with Illinois operations achieving rates in the upper 80% range, sometimes nearing 90%. Addus’s diluted EPS for the period was $5.71, and the company’s financial health score stands at 3.51 out of 5, labeled ‘GREAT’ by InvestingPro.
Operational efficiencies are a key focus, with a caregiver app enabling real-time adjustments to client service hours—automatically flagging over-serving or under-serving scenarios and reducing reliance on service coordinators. Illinois introduced a texting feature during the September 2026 Jefferies Healthcare Services and Technology Conference to streamline communication, cutting phone call volumes. The company also anticipates leveraging Medicaid work requirements, framing its services as a potential solution rather than a burden for states. Illinois rate increases took effect January 1, 2026, with no further increases expected in 2027. Texas legislative sessions in early 2027 could see rate adjustments as early as September 2027.
The deal’s regulatory approval timeline remains contingent, with full synergy realization and margin improvements expected over 12–18 months post-acquisition. Addus’s executives emphasized the strategic value of the acquisition, noting it as one of several potential Gentiva-sized opportunities in the pipeline.
